Work

Abstract CT246: Tagraxofusp plus venetoclax and azacitidine in patients ineligible for intensive chemotherapy with previously untreated CD123+ acute myeloid leukemia: A phase 2 multicenter trial

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct246

Authors: Naval G. Daver, Naveen Pemmaraju, Mikkael A. Sekeres, Amir Fathi, Andrew A. Lane, Anna Compagnoni, Ira Gupta, Alessandra Tosolini, Jessica Garzon, Hagop M. Kantarjian

Institutions: The University of Texas MD Anderson Cancer Center, University of Miami Health System, Sylvester Comprehensive Cancer Center, Massachusetts General Hospital, Dana-Farber Cancer Institute, Menarini Group (Italy)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821687

Cites:

Cited by:

Related to: 10